Thursday, 15 October 2026European Markets
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleYahoo Finance· February 15, 2026

Rampant AI Demand for Memory Is Fueling a Growing Chip Crisis

View original at finance.yahoo.com
Rampant AI Demand for Memory Is Fueling a Growing Chip Crisis (Bloomberg) -- A growing procession of tech industry leaders including Elon Musk and Tim Cook are warning about a global crisis in the making: A shortage of memory chips is beginning to hammer profits, derail corporate plans and inflate price tags on everyth…
Opening lines of the source · Yahoo Finance · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Demand ahead through end of the decade will overwhelm all previous sources of demand and is bigger than anything seen in the past

    80% confidence
  • The structural imbalance between supply and demand is not simply a short-term fluctuation and will last at least through the rest of the year

    80% confidence
  • The memory chip bottleneck is unprecedented

    80% confidence
  • Memory is now the new gold for the AI and automotive sector but will favor those who planned and can spend money for it

    80% confidence
  • HBM demand will increase 70% year-over-year in 2026; HBM will take up 23% of total DRAM wafer output in 2026, up from 19% last year

    80% confidence
  • It is wiser to hold off doing PC business today as prices are almost certain to be higher tomorrow; trend likely to persist unless AI is declared a bubble

    80% confidence
  • DRAM could soon account for as much as 30% of low-end smartphones' bill of materials, tripling from 10% in early 2025

    80% confidence
  • This is the most significant disconnect between demand and supply in terms of magnitude as well as time horizon experienced in 25 years in the industry

    80% confidence
  • There is a 4% gap between supplies and demands for DRAM and 3% for NAND, with actual imbalance likely bigger due to low inventories

    80% confidence
  • DRAM shortages are set to persist across the electronics, telecom, and automotive industries throughout the year; panic buying already visible in auto sector

    80% confidence
  • The company is dealing with the memory crisis hour by hour and day by day

    80% confidence
  • Micron's discontinuation of the Crucial brand started a stampede to secure inventory, driving memory prices to new highs in January

    80% confidence
  • Tesla has two choices: hit the chip wall or make a fab (memory fabrication plant)

    80% confidence
  • Memory chip prices are going parabolic

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,377 source documents archived
Query this data → isubstrate.com